These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 26923004)

  • 1. Adoptive T-Cell Therapy for Cancer.
    Yang JC; Rosenberg SA
    Adv Immunol; 2016; 130():279-94. PubMed ID: 26923004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
    Ikeda H
    Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive cell therapy: past, present and future.
    Cohen JE; Merims S; Frank S; Engelstein R; Peretz T; Lotem M
    Immunotherapy; 2017 Jan; 9(2):183-196. PubMed ID: 28128715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.
    Ott PA; Dotti G; Yee C; Goff SL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e70-e78. PubMed ID: 31099621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes.
    Ikeda H; Shiku H
    Cancer Immunol Immunother; 2015 Jul; 64(7):903-9. PubMed ID: 26041411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.
    Kim SP; Vale NR; Zacharakis N; Krishna S; Yu Z; Gasmi B; Gartner JJ; Sindiri S; Malekzadeh P; Deniger DC; Lowery FJ; Parkhurst MR; Ngo LT; Ray S; Li YF; Hill V; Florentin M; Masi RV; Paria BC; Levin N; Bera A; Hedges EA; Choi A; Chatani PD; Parikh AY; Levi S; Seitter S; Lu YC; Zheng Z; Prickett TD; Jia L; Hernandez JM; Hoang CD; Robbins PF; Goff SL; Sherry RM; Yang JC; Rosenberg SA
    Cancer Immunol Res; 2022 Aug; 10(8):932-946. PubMed ID: 35749374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective mouse model for adoptive cancer immunotherapy targeting neoantigens.
    Hanada KI; Yu Z; Chappell GR; Park AS; Restifo NP
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive T-cell therapy for cancer: The era of engineered T cells.
    Bonini C; Mondino A
    Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive Cellular Therapy (ACT) for Cancer Treatment.
    Yang F; Jin H; Wang J; Sun Q; Yan C; Wei F; Ren X
    Adv Exp Med Biol; 2016; 909():169-239. PubMed ID: 27240459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Infiltrating Lymphocyte Therapy and Neoantigens.
    Robbins PF
    Cancer J; 2017; 23(2):138-143. PubMed ID: 28410302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive cell transfer as personalized immunotherapy for human cancer.
    Rosenberg SA; Restifo NP
    Science; 2015 Apr; 348(6230):62-8. PubMed ID: 25838374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.
    Lu YC; Yao X; Crystal JS; Li YF; El-Gamil M; Gross C; Davis L; Dudley ME; Yang JC; Samuels Y; Rosenberg SA; Robbins PF
    Clin Cancer Res; 2014 Jul; 20(13):3401-10. PubMed ID: 24987109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.
    Parkhurst M; Gros A; Pasetto A; Prickett T; Crystal JS; Robbins P; Rosenberg SA
    Clin Cancer Res; 2017 May; 23(10):2491-2505. PubMed ID: 27827318
    [No Abstract]   [Full Text] [Related]  

  • 15. Exploiting the curative potential of adoptive T-cell therapy for cancer.
    Hinrichs CS; Rosenberg SA
    Immunol Rev; 2014 Jan; 257(1):56-71. PubMed ID: 24329789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer.
    Stevanović S; Pasetto A; Helman SR; Gartner JJ; Prickett TD; Howie B; Robins HS; Robbins PF; Klebanoff CA; Rosenberg SA; Hinrichs CS
    Science; 2017 Apr; 356(6334):200-205. PubMed ID: 28408606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAR T Cell Therapy for Solid Tumors.
    Newick K; O'Brien S; Moon E; Albelda SM
    Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.
    Feldman SA; Assadipour Y; Kriley I; Goff SL; Rosenberg SA
    Semin Oncol; 2015 Aug; 42(4):626-39. PubMed ID: 26320066
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.
    Rosenberg SA
    Annu Rev Med; 1996; 47():481-91. PubMed ID: 8712798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research.
    Wang Z; Cao YJ
    Front Immunol; 2020; 11():176. PubMed ID: 32194541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.